Form 8-K - Current report:
SEC Accession No. 0001213900-25-022444
Filing Date
2025-03-11
Accepted
2025-03-11 07:29:10
Documents
15
Period of Report
2025-03-07
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233826-8k_ispecimen.htm   iXBRL 8-K 26475
2 LETTER FROM WOLF & COMPANY, P.C., DATED MARCH 11, 2025 ea023382601ex16-1_ispecimen.htm EX-16.1 1873
3 GRAPHIC ex16-1_001.jpg GRAPHIC 6634
  Complete submission text file 0001213900-25-022444.txt   212259

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ispc-20250307.xsd EX-101.SCH 3018
5 XBRL LABEL FILE ispc-20250307_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ispc-20250307_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0233826-8k_ispecimen_htm.xml XML 3672
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 25725855
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)